Previous 10 | Next 10 |
GOLDEN, CO / ACCESSWIRE / September 26, 2019 / Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 3rd quarter ended September 24th 2019 financial results of operations. Vitro Diagnostics Inc. ("Vitro Biopharma") is pleased to announce a record 3 rd quarter in Stem C...
Vitro Diagnostics ( OTCPK:VODG ): Q2 Net loss of $58.9k More news on: Vitro Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
GOLDEN, CO / ACCESSWIRE / April 30, 2019 / Vitro Diagnostics, Inc. (OTC PINK: VODG), dba Vitro Biopharma one of the world's emerging biotechnology companies focused on allogeneic Mesenchymal Stem Cell ("MSC") research and clinical products including AlloRx Stem Cells™, Brain Grow Tech...
GOLDEN, CO / ACCESSWIRE / April 2, 2019 / Vitro Diagnostics, Inc. (OTC PINK: VODG), dba Vitro Biopharma announced receipt of a Certificate of Compliance with CLIA (Clinical Laboratory Improvement Amendment) without deficiencies. This allows Vitro Biopharma to perform clinical laboratory ...
Vitro Diagnostics, Inc. ( OTCPK:VODG ): Q1 Net loss of $0.05M. More news on: Vitro Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
GOLDEN, CO / ACCESSWIRE / March 22, 2019 / Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 1 st quarter ended January 31 st 2019 financial results of operations. Vitro Diagnostics Inc. (''Vitro Biopharma'') is pleased to announce a record 1 st quarter in Stem C...
GOLDEN, CO / ACCESSWIRE / March 12, 2019 / Vitro Diagnostics, Inc. (OTC PINK: VODG), dba Vitro Biopharma announced receipt of provisional approval from the National Stem Cell Ethics Committee (NSCEC) of the Ministry of Health of the Commonwealth of the Bahamas for a clinical trial entitl...
Vitro Diagnostics ( OTCPK:VODG ): FY net loss of $0.31M. Revenue of $0.52M (+100.0% Y/Y) Press Release More news on: Vitro Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, ,
Record Revenues from Stem Cell Treatments Lead to 4 th Quarter Break even Cash flow & Growth Continues in Early 2019 GOLDEN, CO / ACCESSWIRE / January 24, 2019 / VitroDiagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its CEO letter to its shareholders including di...
GOLDEN, CO / ACCESSWIRE / December 11, 2018 / VitroDiagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma (''Vitro'') one of theworld's emerging biotechnology companies focused on Umbilical Cord MesenchymalStem Cell (''MSC") research and clinical products has been awarded Certificationto the In...
News, Short Squeeze, Breakout and More Instantly...
Vitro Diagnostics Inc. Company Name:
VODG Stock Symbol:
OTCMKTS Market:
GOLDEN, CO / ACCESSWIRE / October 13, 2020 / Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma announced the revocation of its SEC registration for Vitro Diagnostics, Inc while also announcing its plans for re-registration with the SEC. As noted in our prior releases, the Company...
GOLDEN, CO / ACCESSWIRE / October 1, 2020 / Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, announced its 3rd quarter, ended July 31 st 2020, financial results of operations. Vitro Biopharma recorded 3rd quarter revenues of $132,066 vs $225,191 a decrease of 41% over the compara...
GOLDEN, CO / ACCESSWIRE / July 20, 2020 / Vitro Diagnostics, Inc. (OTC PINK:VODG), dba Vitro Biopharma, announced that it has engaged MaloneBailey L.L.P. (Certified Public Accounting Firm www.malonebailey.com ) as its new auditors that will be auditing the company's consolidated balance sh...